Thursday, September 18, 2025

Psyched Wellness Completes Maximum Tolerated Dosage Study For Amanita Muscaria Extract AME-1

Psyched Wellness (CSE: PSYC) this morning issued a brief press release related to the ongoing pre-clinical trial of its muscimol extract, referred to as AME-1. The firm has received the results from its maximum tolerated dosage study, which was conducted through that of KGK Science.

The study is the first set of toxicology assessments being conducted on the Amanita Muscaria extract. The study for maximum tolerated dosage was required as part of the pre-clinical process, which will now see the company conduct studies focused on the oral toxicity of the product.

Two studies are to be conducted for the next phase of the development, with the firm to conduct both a 14 day and a 90 day oral toxicity study. Once completed, the data will be used to determine effective and safe dosages for human consumption of the extract.

“I am pleased to share the positive results from the individual studies that our CRO is conducting in the pre clinical study on our behalf for AME 1. Today’s results pushes us one step closer to our goal of applying to the FDA for a New Dietary Ingredient and to Health Canada for a Natural Health Product Number.”

Jeff Stevens, CEO of Psyched Wellness

Psyched Wellness last traded at $0.50 on the CSE.


FULL DISCLOSURE: Psyched Wellness is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Psyched Wellness on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Psyched Wellness To Commence Trading Today

Psyched Wellness (CSE: PSYC) is the latest mushroom issue to hit the CSE, with the...

Thursday, October 22, 2020, 08:36:53 AM

Psyched Wellness Sees Amanita Muscaria Approved As Medicinal Organism By Health Canada

After more than a years worth of development work, Psyched Wellness (CSE: PSYC) this morning...

Wednesday, November 3, 2021, 08:10:25 AM

Psyched Wellness Completes First Step In Study Identifying Potential Of Muscimol

Psyched Wellness (CSE: PSYC) has completed the first step in identifying the medicinal potential of...

Thursday, January 14, 2021, 06:58:13 AM

David Nutt: Amanita Muscaria Due For More Research – The Daily Dive

Today on the Daily Dive, our host Cassandra Leah sits down with Dr David Nutt,...

Wednesday, March 10, 2021, 01:30:00 PM

Psyched Wellness Adds Amanita Muscaria Expert To Advisory Board

Kevin Feeney has joined the advisory board of that of Psyched Wellness (CSE: PSYC) as...

Thursday, November 26, 2020, 07:16:39 AM